US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

308.91

+0.28000.09%

Pre-market: 299.82-9.0900-2.94%08:08 EDT

Volume:120.36K

Turnover:37.06M

Market Cap:36.59B

PE:-185.82

High:309.68

Open:308.84

Low:306.35

Close:308.63

52wk High:330.63

52wk Low:170.99

Shares:118.45M

Float Shares:75.99M

Volume Ratio:0.65

T/O Rate:0.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6624

EPS(LYR):-6.1240

ROE:-4.98%

ROA:-1.06%

PB:9.70

PE(LYR):-50.44

Loading ...

Overview Company News Filings

BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment

MT Newswires Live

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

MT Newswires Live

BeOne Medicines Says EU Approves New Brukinsa Tablet That Reduces Daily Pill Count

MT Newswires Live

BeOne Medicines’ Brukinsa tablet formulation approved by European Commission

BeOne Medicines (ONC) Is Up 11.5% After Profit Reversal and Upgraded 2025 Outlook Has the Bull Case Changed?

Simply Wall St.

This Medical Stock With Blockbuster Cancer Drug Clears Entry Amid 923% Earnings Growth

This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine

CCB International Maintains Cautious Optimism on Chinese Pharmaceutical Stocks Despite High Valuations, Assigns "Outperform" Rating to BeiGene (06160)

BEIGENE (06160) Grants Restricted Stock Units Involving Approximately 344 Million American Depositary Shares

RBC Capital Remains a Buy on BeOne Medicines (ONC)

RBC Raises Price Target on BeOne Medicines to $364 From $349, Keeps Outperform Rating

MT Newswires Live

Beone Medicines : Leerink Partners Raises Target Price to $345 From $334

THOMSON REUTERS

Nomura Adjusts BeOne Medicines Price Target to $366.06 From $352.60, Maintains Buy Rating

MT Newswires Live

AI Play Arista Hits Record High, Joins 3 Best Stock Lists: Build Your Growth Stock Watchlist With These Just Updated Screens

BeOne Medicines Q2 Adjusted Earnings, Revenue Rise; 2025 Revenue Guidance Increased

MT Newswires Live

BeOne Medicines AG expected to post earnings of 11 cents a share - Earnings Preview

BeOne Medicines Gets European Priority Medicines Designation for BGB-16673

MT Newswires Live

Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday

MT Newswires Live

BeOne Medicines's Lung Cancer Treatment Recommended for Approval by EMA Panel

MT Newswires Live

Nomura Adjusts BeOne Medicines Price Target to $352.60 From $347.02, Maintains Buy Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ONC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":308.91,"timestamp":1756238400000,"preClose":308.63,"halted":0,"volume":120362,"hourTrading":{"tag":"盘前","latestPrice":299.82,"preClose":308.91,"latestTime":"08:08 EDT","volume":167,"amount":49946.02099,"timestamp":1756296481181},"delay":0,"floatShares":75991800,"shares":118450715,"eps":-1.662384,"marketStatus":"Pre-Mkt","change":0.28,"latestTime":"08-27 08:21:24 EDT","open":308.84,"high":309.68,"low":306.35,"amount":37061475.8635,"amplitude":0.01079,"askPrice":303,"askSize":300,"bidPrice":298.57,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.662384,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756301400000},"marketStatusCode":1,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":308.91,"preHourTrading":{"tag":"盘前","latestPrice":299.82,"preClose":308.91,"latestTime":"08:08 EDT","volume":167,"amount":49946.02099,"timestamp":1756296481181},"postHourTrading":{"tag":"盘后","latestPrice":308.91,"preClose":308.91,"latestTime":"17:18 EDT","volume":1981,"amount":611881.34,"timestamp":1756243113362},"volumeRatio":0.6507369596906504,"impliedVol":0.3804,"impliedVolPercentile":0.0309},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":75991800,"roa":"-1.06%","roe":"-4.98%","lyrEps":-6.124009,"volumeRatio":0.6507369596906504,"shares":118450715,"dividePrice":0,"high":309.68,"amplitude":0.01079,"preClose":308.63,"low":306.35,"week52Low":170.99,"pbRate":"9.70","psRate":"8.02","week52High":330.63,"institutionHeld":0,"latestPrice":308.91,"committee":-0.993355,"eps":-1.662384,"divideRate":0,"volume":120362,"delay":0,"ttmEps":-1.662384,"open":308.84,"prevYearClose":184.71,"prevWeekClose":313.67,"prevMonthClose":301.13,"prevQuarterClose":242.07,"fiveDayClose":312.51,"twentyDayClose":305.74,"sixtyDayClose":245.58,"earningDate":1756483200000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-Market","dateTimestamp":1756526400000,"actualEps":null},{"market":"US","date":"2025-05-07","symbol":"ONC","fiscalQuarterEnding":"2025/03","expectedEps":-0.71,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746590400000,"reportTimeType":"pre","actualEps":1.22},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3043,"buy":0.6522,"hold":0.0435,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6522,"analysts":23,"updateTime":1754712000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-08-26","current":-191.161696,"percent":0.022436,"low":-199.046505,"twenty":-72.396751,"median":-40.29759,"eighty":-23.55354,"high":-19.234246,"avg":-48.990687,"sd":36.50745,"marketCap":33958154903},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-26","current":-191.161696,"twenty":-72.396751,"median":-40.29759,"eighty":-23.55354,"marketCap":33958154903}],"updateTime":1756293770591},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2562642717","title":"BeOne Says EU Approves Tevimbra Combo for Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2562642717","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562642717?lang=en_us&edition=fundamental","pubTime":"2025-08-27 18:37","pubTimestamp":1756291075,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Wednesday that the European Commission has approved Tevimbra, in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by Tevimbra alone after surgery, for adults with resectable non-small cell lung cancer at high risk of recurrence.The company said the approval is based on the final analysis of Phase 3 trial data, which showed that the Tevimbra regimen significantly improved overall survival compared to chemotherapy plus placebo.With a median follow-up of 38.5 months, the study also confirmed sustained benefits in event-free survival, major pathological response, and pathological complete response across various patient subgroups-regardless of PD-L1 levels, disease stage, or tumor type, the company said.Tevimbra is already approved in the EU for four indications related to lung cancer and other cancer treatments.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4156","BK4139","ONC","BK4585","BK4526"],"gpt_icon":0},{"id":"2562324229","title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324229","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562324229?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:22","pubTimestamp":1756128164,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower pre-bell Monday, with the Health Care Select Sector SPDR Fund  inactive and the iShares Biotechnology ETF  down 0.2%.Argenx  stock was nearly 4% higher after the company said a phase 3 study of its drug Vyvgart met its primary endpoint in treating patients with AChR-Ab seronegative generalized myasthenia gravis, an autoimmune disease.Axogen  shares were down more than 10% after the company said the US Food and Drug Administration has extended the review deadline for its marketing application for the Avance Nerve Graft by three months.BeOne Medicines  shares were up more than 2% after the company said it has agreed to sell its royalty rights, excluding China, on Amgen's  lung cancer drug, Imdelltra, to Royalty Pharma  for up to $950 million.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","BK4581","LU2112291526.USD","XLV","IE00BJT1NW94.SGD","BK4534","IE00B4R5TH58.HKD","BK4139","AXGN","BK4505","BK4082","LU0289739699.SGD","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4533","IE00BJJMRZ35.SGD","SG9999001440.SGD","BK4585","BK4599","IE0009355771.USD","LU0122379950.USD","LU2242646821.SGD","LU0868494617.USD","ARGX","LU1983299246.USD","LU0320765992.SGD","BK4007","RPRX","LU0058720904.USD","LU2468319806.SGD","BK4588","LU1023059063.AUD","LU1571399168.USD","LU2242652126.USD","ONC","LU1061106388.HKD","LU1057294990.SGD","IBB","LU0109394709.USD","IE0002141913.USD","LU2089984988.USD","BK4566","BK4526","AMGN"],"gpt_icon":0},{"id":"2561695334","title":"BeOne Medicines Says EU Approves New Brukinsa Tablet That Reduces Daily Pill Count","url":"https://stock-news.laohu8.com/highlight/detail?id=2561695334","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561695334?lang=en_us&edition=fundamental","pubTime":"2025-08-21 18:38","pubTimestamp":1755772684,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Thursday that the European Commission has approved a new tablet version of Brukinsa for all existing indications.The company said the new 160 mg film-coated tablets allow patients to take just two pills per day instead of four. The tablets are also smaller and easier to swallow than the original capsules, it added.Brukinsa is used to treat certain blood cancers by blocking a protein that promotes the growth of cancerous B cells.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","BK4139","BK4156","ONC","BK4526","BK4585"],"gpt_icon":0},{"id":"2561466648","title":"BeOne Medicines’ Brukinsa tablet formulation approved by European Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2561466648","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561466648?lang=en_us&edition=fundamental","pubTime":"2025-08-21 18:05","pubTimestamp":1755770744,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) announced that the European Commission has approved a new film-coated tablet formulation of Brukinsa – zanubrutinib – for all...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-brukinsa-tablet-formulation-approved-by-european-commission-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-brukinsa-tablet-formulation-approved-by-european-commission-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","BK4139","BK4585","BK4526","ONC"],"gpt_icon":0},{"id":"2560192346","title":"BeOne Medicines (ONC) Is Up 11.5% After Profit Reversal and Upgraded 2025 Outlook Has the Bull Case Changed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2560192346","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560192346?lang=en_us&edition=fundamental","pubTime":"2025-08-16 14:06","pubTimestamp":1755324363,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd. recently reported second quarter 2025 earnings, showing revenue of US$1.32 billion and net income of US$94.32 million, marking a reversal from net losses in the previous year.\nThe company also raised its full-year 2025 revenue guidance and now expects positive GAAP operating income, highlighting improved operational performance and momentum in its oncology business.\nWe'll explore how BeOne's move to profitability and higher revenue guidance affect its investment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-is-up-115-after-profit-reversal-and-upgr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","ONC"],"gpt_icon":0},{"id":"2559948144","title":"This Medical Stock With Blockbuster Cancer Drug Clears Entry Amid 923% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2559948144","media":"Blockhead","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559948144?lang=en_us&edition=fundamental","pubTime":"2025-08-16 00:55","pubTimestamp":1755276900,"startTime":"0","endTime":"0","summary":"This medical stock is clearing an entry as profit soars. It is seeing strong growth for its blockbuster cancer drug and funds are loading up.","market":"us","thumbnail":"https://www.investors.com/wp-content/uploads/2025/08/Stock-MoneyPharma-shut-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/08/Stock-MoneyPharma-shut-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/stock-lists/stock-spotlight/medical-stock-beone-medicines-onc-blockbuster-cancer-drug-entry-earnings-growth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4585","BK4139","BK4526","ONC"],"gpt_icon":0},{"id":"2559917851","title":"This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine","url":"https://stock-news.laohu8.com/highlight/detail?id=2559917851","media":"Blockhead","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559917851?lang=en_us&edition=fundamental","pubTime":"2025-08-15 22:04","pubTimestamp":1755266640,"startTime":"0","endTime":"0","summary":"Biotech stocks are performing well in the stock market in August and a few in the IBD 50 have formed bases with clear buy points.","market":"hk","thumbnail":"https://www.investors.com/wp-content/uploads/2020/06/Stock-biotech-06-adobe-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2020/06/Stock-biotech-06-adobe-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/stock-lists/ibd-50/stock-market-sp500-eye-treatment-stock/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["BK4585","LU2065171311.SGD","IBB","ONC","BK4526","TARS","LU2065171402.SGD","BK4139","ARQT","MEDP","BK4588","BK4121","BK4581","LU2065169927.USD","XBI","LU2065170008.USD","BK4007"],"gpt_icon":0},{"id":"1187058234","title":"CCB International Maintains Cautious Optimism on Chinese Pharmaceutical Stocks Despite High Valuations, Assigns \"Outperform\" Rating to BeiGene (06160)","url":"https://stock-news.laohu8.com/highlight/detail?id=1187058234","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187058234?lang=en_us&edition=fundamental","pubTime":"2025-08-14 17:38","pubTimestamp":1755164281,"startTime":"0","endTime":"0","summary":"CCB International released a research report maintaining a cautiously optimistic stance on China's pharmaceutical industry. The firm noted that since early 2025, Hong Kong biotech stocks have risen...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","LU2328871848.SGD","BK4139","LU0307460666.USD","BK1161","BK0175","BK1500","LU0588546209.SGD","BK0010","600056","BK1583","LU1969619763.USD","BK1588","BK4585","688235","BK0188","06160","ONC","BK0028","BK0082","BK0239","BK4526","BK0185"],"gpt_icon":0},{"id":"1198471025","title":"BEIGENE (06160) Grants Restricted Stock Units Involving Approximately 344 Million American Depositary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1198471025","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198471025?lang=en_us&edition=fundamental","pubTime":"2025-08-14 16:58","pubTimestamp":1755161899,"startTime":"0","endTime":"0","summary":"BEIGENE (06160) announced that on August 8, 2025, the Board Compensation Committee granted restricted stock units involving a total of 34,361 American Depositary Shares to 375 grantees under the terms of the 2016 Option and Incentive Plan.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","BK1588","688235","BK1161","BK4139","LU0588546209.SGD","BK0239","BK4585","06160","LU1969619763.USD","BK1500","BK1583","LU2328871848.SGD","BK4526","ONC"],"gpt_icon":0},{"id":"2557988925","title":"RBC Capital Remains a Buy on BeOne Medicines (ONC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2557988925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557988925?lang=en_us&edition=fundamental","pubTime":"2025-08-08 01:05","pubTimestamp":1754586319,"startTime":"0","endTime":"0","summary":"In a report released today, Leonid Timashev from RBC Capital maintained a Buy rating on BeOne Medicines, with a price target of $364.00. The compan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-beone-medicines-onc-blurbs-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-beone-medicines-onc-blurbs-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0310800379.SGD","MDCO","ONC","BK4526","BK4139","LU0029864427.USD","LU0128525929.USD","LU1267930573.SGD","BK4207","LU0708994859.HKD"],"gpt_icon":0},{"id":"2557563460","title":"RBC Raises Price Target on BeOne Medicines to $364 From $349, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2557563460","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557563460?lang=en_us&edition=fundamental","pubTime":"2025-08-07 20:27","pubTimestamp":1754569623,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) has an average rating of buy and mean price target of $351.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","MDCO"],"gpt_icon":0},{"id":"2557552001","title":"Beone Medicines : Leerink Partners Raises Target Price to $345 From $334","url":"https://stock-news.laohu8.com/highlight/detail?id=2557552001","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557552001?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:19","pubTimestamp":1754565570,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250807:nFWN3TZ1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","BK4139","688235","BK4585","BK4526","ONC"],"gpt_icon":0},{"id":"2557655279","title":"Nomura Adjusts BeOne Medicines Price Target to $366.06 From $352.60, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2557655279","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557655279?lang=en_us&edition=fundamental","pubTime":"2025-08-07 19:13","pubTimestamp":1754565211,"startTime":"0","endTime":"0","summary":"Nomura Adjusts BeOne Medicines Price Target to $366.06 From $352.60, Maintains Buy Rating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","NMR","MDCO"],"gpt_icon":0},{"id":"2557585870","title":"AI Play Arista Hits Record High, Joins 3 Best Stock Lists: Build Your Growth Stock Watchlist With These Just Updated Screens","url":"https://stock-news.laohu8.com/highlight/detail?id=2557585870","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557585870?lang=en_us&edition=fundamental","pubTime":"2025-08-07 07:07","pubTimestamp":1754521620,"startTime":"0","endTime":"0","summary":"Here are today's top growth stocks like Arista Networks that have just been added to the IBD stock lists, including the IBD 50, IPO Leaders and the IBD Big Cap 20.","market":"nz","thumbnail":"https://www.investors.com/wp-content/uploads/2018/03/ibdstocksupdate3-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2018/03/ibdstocksupdate3-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/research/ai-play-arista-hits-record-high-joins-3-best-stock-lists-build-your-growth-stock-watchlist-with-these-just-updated-screens/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU2663582299.SGD","NEM","CCJ.AU","TMDX","ALNY","CRDO","ONC","RBRK","SEI.AU","WDC","HNGE","MRCY","KNSA","HMY.AU","UTI","SRAD","ARGX","ARQT","LRCX","BK4147","PWR.AU","IE00BN0W2V16.EUR","FFTY","PWR","HMY","BGSX","SEI","DAVE","03145","IE00B66KJ199.SGD","AUGO","LU0082616367.USD","RSI","LU0231459107.USD","PTC","SNEX","AMD.AU","ATAT","LU0957791311.USD","AXON","NEM.AU","ANET","CCJ"],"gpt_icon":1},{"id":"2557937824","title":"BeOne Medicines Q2 Adjusted Earnings, Revenue Rise; 2025 Revenue Guidance Increased","url":"https://stock-news.laohu8.com/highlight/detail?id=2557937824","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557937824?lang=en_us&edition=fundamental","pubTime":"2025-08-06 18:35","pubTimestamp":1754476503,"startTime":"0","endTime":"0","summary":"BeOne Medicines  reported Q2 adjusted earnings Wednesday of $2.25 per ADS, up from $0.22 a year earlier.No comparable FactSet estimate was available.Revenue for the quarter ended June 30 was $1.32 billion, up from $929.2 million a year earlier.Analysts polled by FactSet expected $1.24 billion.The company now expects 2025 total revenue of $5.0 billion to $5.3 billion, compared with its prior outlook of $4.9 billion to $5.3 billion. Analysts surveyed by FactSet expect $5.13 billion.BeOne Medicines shares were up about 4.5% in recent pre-market activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","MDCO"],"gpt_icon":0},{"id":"2556853833","title":"BeOne Medicines AG  expected to post earnings of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556853833","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556853833?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:02","pubTimestamp":1754305326,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG  expected to post earnings of11cents a share - Earnings Preview BeOne Medicines AG ONC.OQ, ONC.O is expected to  show a rise in quarterly revenue when it reports  results on August ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL8N3TW0LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"gpt_icon":0},{"id":"2556783791","title":"BeOne Medicines Gets European Priority Medicines Designation for BGB-16673","url":"https://stock-news.laohu8.com/highlight/detail?id=2556783791","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556783791?lang=en_us&edition=fundamental","pubTime":"2025-08-01 00:29","pubTimestamp":1753979398,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Thursday its investigational BGB-16673 protein degrader, which is intended to treat Waldenstrom's macroglobulinemia, received Priority Medicines designation from the European Medicines Agency.BeOne Medicines said that, further to the designation, the EMA's Committee for Medicinal Products for Human Use provided a \"positive\" view on the company's EU Orphan Drug Designation application for BGB-16673 in Waldenstrom's macroglobulinemia, a rare type of cancer.A final decision regarding the application is expected in the coming weeks, BeOne Medicines said.The company said that the Priority Medicines designation was based on data that showed usage of BGB-16673 resulted in anti-tumor activity in B-cell malignancies.BeOne Medicines shares were up nearly 1% in recent Thursday trading.Price: 301.31, Change: +1.37, Percent Change: +0.46","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","MDCO","BGB","ONC","BK4139","BK4526"],"gpt_icon":0},{"id":"2554772518","title":"Sector Update: Health Care Stocks Flat to Lower Pre-Bell Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772518","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554772518?lang=en_us&edition=fundamental","pubTime":"2025-07-28 21:23","pubTimestamp":1753708994,"startTime":"0","endTime":"0","summary":"Health care stocks were flat to lower pre-bell Monday, with The Health Care Select Sector SPDR Fund  down 0.1% and the iShares Biotechnology ETF   inactive.Revvity  shares were down more than 9% after the company reported lower fiscal Q2 adjusted earnings and cut its fiscal 2025 non-GAAP EPS guidance.Celcuity  stock was up more than 230% after the company said a phase 3 trial of its drug gedatolisib, combined with fulvestrant, with and without palbociclib, demonstrated a \"statistically significant and clinically meaningful\" improvement in progression-free survival in a type of breast cancer.BeOne Medicines  stock was up more than 2% after the company said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4526","IBB","BK4139","ONC","CELC","XLV","BK4581","RVTY","BK4121","BK4585"],"gpt_icon":0},{"id":"2554773971","title":"BeOne Medicines's Lung Cancer Treatment Recommended for Approval by EMA Panel","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773971","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554773971?lang=en_us&edition=fundamental","pubTime":"2025-07-28 18:49","pubTimestamp":1753699748,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Monday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of Tevimbra for treating adults with resectable non-small cell lung cancer at high risk of recurrence.The recommendation covers Tevimbra for use with chemotherapy as neoadjuvant treatment and continued as monotherapy as adjuvant treatment.The drugmaker said the recommendation was based on a phase 3 trial, where the treatment met key goals of event-free survival and major pathologic response at the interim analyses.Shares of the company were up 2.6% in Monday's premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4526","BK4139","BK4081","MDCO","EMA","ONC"],"gpt_icon":0},{"id":"2552464767","title":"Nomura Adjusts BeOne Medicines Price Target to $352.60 From $347.02, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2552464767","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552464767?lang=en_us&edition=fundamental","pubTime":"2025-07-18 19:09","pubTimestamp":1752836979,"startTime":"0","endTime":"0","summary":"Nomura Adjusts BeOne Medicines Price Target to $352.60 From $347.02, Maintains Buy Rating","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NMR","ONC","MDCO"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":92,"code":"91000000","status":"200"}]}}